Close Menu

cytogenetics

Illumina's microarray revenues increased 1 percent in the first quarter due to demand from consumer genetics companies, researchers running genome-wide association studies, and clients of BlueGnome's chips for cytogenetics and pre-implantation genetic diagnosis, the company said

Illumina and Kindstar Global announced last week that they have made an agreement that allows Kindstar to offer a set of Illumina products, including the Infinium Dx CytoSNP-12 BeadChip assay, to its Chinese clients.

Oxford Gene Technology said this week that it has signed an agreement with the Cancer Cytogenomics Microarray Consortium to use the organization's suggested cancer array design to develop and launch its own whole-genome, cancer-specific chip.

Cancer Genetics this week said that its microarray-based test for diagnosing and monitoring diffuse large B-cell lymphoma has been deemed by regulatory authorities to be compliant with the US Clinical Laboratory Improvement Amendments as well as New York State regulations.

What will regulatory clearance mean for companies that manufacture chromosomal microarrays?

This article was originally posted on Feb. 1

By the end of next year, all of the large array vendors could have US Food and Drug Administration-cleared products on the market for postnatal constitutional cytogenetics.

Illumina's acquisition of BlueGnome has provided a boost for its array business.

SAN FRANCISCO — Illumina will not be the only array vendor submitting a cytogenetics-focused array to the US Food and Drug Administration for clearance this quarter.

Illumina CEO Jay Flatley provided an update on the company's array business at the JP Morgan Global Healthcare Conference in San Francisco this week.

Pages

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.